On May 2, Shanghai Tongyong Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharm (HK.01177), became a key enterprise on the white list approved by the Shanghai Municipal Government for resumption of work and production. The first batch of 15 people have been stationed in the plant on May 11 and will be managed in a closed loop according to the epidemic prevention and control requirements thereafter. After two days of silence and no abnormal nucleic acid testing results, they will be officially put to work and take the lead in blowing the "trumpet" of resuming work and production!

The first batch of staff of Shanghai Tongyong Pharmaceutical Co., Ltd. resumed work mainly in the positions of inspection, warehouse, production and office, and their main task was to complete the inspection and release of products which have been produced before the shutdown yet to be inspected and the production preparation work. At the same time, the company set up a special team for epidemic prevention and control and production operation, established an internal organizational structure for epidemic prevention and control, and strictly enforced the requirements of "one enterprise, one plan" for epidemic prevention and control, including staff health management, introductory testing management, work environment management, production and transportation management, logistic support management and emergency prevention and control management. The company will implement responsible persons and work responsibilities, reserve emergency management teams, and implement closed production and operation.

Shanghai Tongyong Pharmaceutical Co., Ltd., located in Xinzhuang Industrial Park, is mainly engaged in the production and sales of pharmaceuticals and health food business. The topical drugs produced by the company have always been one of the essential medicines for people's families and are important products for people's livelihood. Since the outbreak of the epidemic, the park has been shut down and so has the company, which faced the painful and difficult situation of having no goods to sell and cut off from most of the drug market. If we do not resume production, it will bring inconvenience to the life of the general public, and the company will lose more market users. Therefore, after Shanghai gradually opened to resume work, in order to ensure the basic drug and material needs of users during the epidemic, Shanghai Tongyong Pharmaceutical Co., Ltd. actively responded to the call and organized to resume work and production at the first time. After learning about the policy of resuming work, the company immediately maintained communication with Xinzhuang Industrial Park, stepped up application procedures for resumption of work permits and vehicle passes, procured basic living materials for employees stationed at the plant, and made full preparations to secure the arrival of production, quality, logistics, and canteen logistics personnel.